FILE PHOTO: An employee leaves a store of Reliance Industries Ltd, controlled by Mukesh Ambani, one of India’s richest men, at a market in Kolkata, India, September 10, 2016. Picture taken September 10, 2016. REUTERS/Rupak De Chowdhuri
August 18, 2020
BENGALURU (Reuters) – Reliance Industries Ltd <RELI.NS> has acquired a majority stake in online pharmacy Netmeds for about 6.2 billion rupees ($83.08 million) in cash, days after e-commerce giant Amazon.com Inc <AMZN.O> launched an online drug sales service in India.
The oil-to-telecoms conglomerate said (https://www.bseindia.com/xml-data/corpfiling/AttachLive/cd4afca2-0bb5-4744-8ccb-f37a05fa65f2.pdf) late on Tuesday its investment represents about 60% holding in Vitalic Health Pvt. Ltd. and 100% direct ownership of its subsidiaries.
Vitalic and its subsidiaries, collectively known as Netmeds, were incorporated in 2015. Netmeds is a licensed e-pharma portal that offers authenticated prescription and over the counter (OTC) medicine along with other health products in India.
The COVID-19 crisis, which spurred a wave of online shopping, has led to increased competition between Amazon, Walmart-owned Flipkart, Reliance’s upstart online grocery service, JioMart and a range of other smaller players for a share in the world’s second most populous country.
India is yet to finalize regulations for online drug sales, or e-pharmacies, but growth of online sellers such as Medlife, Netmeds, Temasek-backed PharmEasy and Sequoia Capital-backed 1mg has threatened traditional drug stores.
Many trader groups are against e-pharmacies, saying they would lead to sale of medicines without proper verification.
(Reporting by Bhargav Acharya and Anirudh Saligrama in Bengaluru; Editing by Shinjini Ganguli)
